| ADMET | absorption: distribution, metabolism, excretion, toxicity |
| AKT | protein kinase B |
| ALK | anaplastic lymphoma kinase |
| BFE | binding free energy |
| DFG | Asp-Phe-Gly |
| EGF | epidermal growth factor |
| FDA | food and drug administration |
| GF | goodness of fit |
| GFA | genetic function approximation |
| GH | Güner-Henry |
| GOLD | genetic optimization for ligand docking |
| GROMACS | GROningen MAchine for Chemical Simulations |
| HBD | hydrogen bond donor |
| HBA | hydrogen bond acceptor |
| Hy | hydrophobic |
| IC50 | half maximal inhibitory concentration |
| LINCS | LINear Constraint Solver |
| LUAD | lung adenocarcinoma |
| LUSC | lung squamous cell carcinoma |
| MD | molecular dynamics |
| MT | mutant |
| mTOR | mammalian target of rapamycin |
| MM/PBSA | molecular mechanics/poisson-boltzmann surface area |
| NI | negative ionizable |
| Nrf2 | nuclear factor erythroid 2-related factor 2 |
| NVT | constant number of particles, volume and temperature |
| NPT | constant number of particles, pressure and temperature |
| NSCLC | non-small cell lung cancer |
| PDB | protein data bank |
| PI | positive ionizable |
| PI3K | phosphoinositide 3-kinase |
| P-loop | phosphate binding loop |
| PME | Particle mesh Ewald |
| RA | ring aromatic |
| RTK | receptor tyrosine kinase |
| ROS-1 | c-ros oncogene 1 |
| Ro5 | rule of five |
| RMSD | root mean square deviation |
| VMD | visual molecular dynamics |
| WT | wild-type |